Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients.

MLA

Joo, Ji Hyeon, et al. “Impact of Pathologic Diagnosis of Internal Mammary Lymph Node Metastasis in Clinical N2b and N3b Breast Cancer Patients.” Breast Cancer Research and Treatment, vol. 166, no. 2, Nov. 2017, pp. 511–18. EBSCOhost, https://doi.org/10.1007/s10549-017-4422-2.

APA

Joo, J. H., Kim, S. S., Ahn, S.-D., Choi, E. K., Jung, J. H., Jeong, Y., Ahn, S. H., Son, B. H., Lee, J. W., Kim, H. J., Go, B. S., Kim, H. H., Cha, J. H., Shin, H. J., & Chae, E. Y. (2017). Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients. Breast Cancer Research and Treatment, 166(2), 511–518. https://doi.org/10.1007/s10549-017-4422-2

Chicago

Joo, Ji Hyeon, Su Ssan Kim, Seung-Do Ahn, Eun Kyung Choi, Jin Hong Jung, Yuri Jeong, Sei Hyun Ahn, et al. 2017. “Impact of Pathologic Diagnosis of Internal Mammary Lymph Node Metastasis in Clinical N2b and N3b Breast Cancer Patients.” Breast Cancer Research and Treatment 166 (2): 511–18. doi:10.1007/s10549-017-4422-2.